Chronic Lyme disease and persistent symptoms after Lyme infection often involve co-infections (Bartonella, Babesia, Anaplasma), biofilm formation, and immune dysregulation. The Strategy covers improved testing options (IGeneX, T-cell assays), biofilm disruption, pulsed antimicrobial therapy (herbal and pharmaceutical), and the supportive care needed for recovery from a chronic tick-borne disease load.
Read Time: 20 Minutes
Clinical Focus: Borrelia, Co-Infections (Bartonella/Babesia), Biofilms
You might remember a tick bite ten years ago. You might not. What you have is "the aches." It feels like the flu, but it never goes away. Your knees hurt today, your shoulders hurt tomorrow. You have air hunger or night sweats. You have been told your standard Lyme test is negative, so it must be something else.
Standard ELISA testing misses up to 50% of chronic Lyme cases. The bacterium hides in tissue, covers itself in biofilm, and dodges the immune response. The Lyme and Chronic Fatigue Strategy is the playbook for patients with persistent post-tick syndromes: better testing, biofilm disruption, pulsed antimicrobial therapy, and the supportive care needed for actual recovery.
Why are standard Lyme tests inadequate for chronic disease?
The standard two tier ELISA and Western blot tests look for the immune response (antibodies) to Borrelia burgdorferi. They were designed and validated primarily for acute, early Lyme disease. They fall short for chronic and persistent infection for several reasons.
- Antibody response is variable in chronic disease: Patients with long standing infection often have suppressed or atypical antibody patterns.
- Strain diversity: Borrelia has many strains and species (B. burgdorferi, B. mayonii, B. miyamotoi). Standard tests do not cover all of them.
- Co-infections are not screened: Standard Lyme panels do not test for Bartonella, Babesia, Anaplasma, Ehrlichia, or Powassan virus.
- Biofilm and persister cells: Borrelia can form biofilms and persister cells that evade both immune detection and antibody testing.
How do co-infections complicate the picture?
Ticks are dirty needles. They do not just carry Lyme.
- Bartonella: Causes "stretch marks" (striae not from weight gain), foot pain, anxiety, rage, and cognitive disturbance. Often missed.
- Babesia: A red cell parasite (similar mechanism to malaria). Causes night sweats, air hunger, headaches, and worse fatigue.
- Anaplasma and Ehrlichia: Cause fevers, chills, low white blood cell counts, and elevated liver enzymes. Often present in early disease and missed.
- Powassan virus: A neurotropic virus transmitted in minutes after tick attachment. Less common but increasingly recognized.
If you treat Lyme but miss Babesia, you do not get better. The co-infections often need separate treatment, and the order of operations matters.
What does the diagnostic workup look like?
We layer testing rather than relying on a single result.
Standard Tier
- Two tier ELISA and Western blot: We still order it because positives are diagnostic. We just do not use a negative to rule Lyme out.
Specialty Testing
- IGeneX or Vibrant Wellness Lyme panels: Look at additional bands and species not covered by standard testing.
- T-cell based assays (like LymeSpot or T-Lab): Detect cellular immune response to Borrelia, often positive when antibody tests are negative.
- Co-infection panels: Bartonella IgG/IgM, Bartonella PCR or FISH, Babesia IgG/IgM, Babesia PCR for B. microti and B. duncani.
- CD57 marker: A specific natural killer cell subset that is often suppressed in chronic Lyme. Not a stand alone diagnostic but useful as a trend marker.
- C4a complement: Often elevated in chronic biotoxin states including Lyme.
Supportive Workup
- Inflammation: hs-CRP, ESR, ferritin, fibrinogen.
- Hormonal: Full thyroid, AM cortisol, DHEA-S, sex hormones. Chronic infection drives endocrine dysfunction.
- Mitochondrial markers: Lactate, pyruvate, organic acids when indicated.
- Autonomic: 10 minute lean test for orthostatic intolerance (POTS overlap is common).
What is the strategic roadmap for chronic Lyme treatment?
Phase 1: Provocation and Testing
We complete the workup and identify the dominant pathogens and downstream effects. We also stabilize basic systems: sleep, nutrition, hydration, and electrolyte balance. Many patients are in a fragile state, and starting intensive antimicrobial therapy in an unstable patient causes severe Herxheimer reactions.
Phase 2: Breaking the Biofilm
Fishtown Medicine
A 90-minute conversation with Dr. Ash. A written plan you can actually follow.
You cannot clear the bug if you cannot reach it. Biofilm disruption is often the difference between a year of failed antimicrobial therapy and actual progress.
- Stevia leaf extract: Lab evidence supports antibiofilm activity against Borrelia.
- Cistus incanus tea: Polyphenol rich, used for biofilm disruption and as a daily preventive.
- Lumbrokinase or serrapeptase: Enzymes with biofilm disrupting and fibrinolytic activity. Used under supervision because of bleeding risk.
- Monolaurin: A coconut derived fatty acid with broad antimicrobial activity.
Phase 3: The Antimicrobial Phase (Pulsed)
We pulse therapy because Borrelia has a slow replication cycle (several weeks) and switches between active and dormant forms. Continuous treatment can drive the organism into persister states. Pulsed treatment catches the spirochetes when they emerge.
- Pharmaceutical options: Doxycycline, azithromycin, cefuroxime, dapsone, and others. Selection depends on the dominant pathogen, prior treatments, and patient tolerance.
- Herbal options: Cryptolepis, Japanese knotweed, cat's claw, andrographis, sida acuta, alchornea. We often prefer herbal protocols for long term use because of the lower side effect profile.
- Co-infection specific therapy: Bartonella often needs combination therapy (rifabutin or rifampin plus a quinolone or azalide). Babesia needs antimalarial agents (atovaquone plus azithromycin, or cryptolepis based herbal protocols).
- Pulsed schedule: Many protocols use 4 days on, 3 days off, or 2 weeks on, 1 week off. The schedule depends on the specific medication and patient response.
Phase 4: System Repair and Supportive Care
Clearing the pathogens is only part of the work. The downstream damage needs repair.
- Mitochondrial support: CoQ10 (ubiquinol), PQQ, NAD precursors, magnesium.
- Detoxification support: Binders (activated charcoal, bentonite clay, cholestyramine in select cases), glutathione, NAC, milk thistle.
- Hormonal restoration: Thyroid, adrenal, sex hormone optimization based on labs.
- Autonomic regulation: Salt and volume expansion, compression, recumbent exercise.
- Mast cell support: Many chronic Lyme patients develop mast cell activation that needs separate stabilization.
Actionable Steps for Suspected Chronic Lyme
- Get the right testing. Standard Lyme panel plus IGeneX or Vibrant Lyme panel plus co-infection panel (Bartonella, Babesia, Anaplasma).
- Address the foundations first: sleep, nutrition, hydration, electrolytes, basic mitochondrial support. Many patients improve substantially before starting antimicrobials.
- Find a physician who knows the literature. The standard infectious disease community remains divided on chronic Lyme. We work alongside ILADS trained physicians for complex cases.
- Plan for a long course. Most chronic Lyme treatment runs 6 to 24 months. Quick fixes are not realistic.
Scientific References
- Aucott, J. N., et al. (2013). Post-treatment Lyme disease syndrome symptomatology and the impact on life functioning. Quality of Life Research, 22(1), 75-84.
- Feng, J., et al. (2020). Identification of essential oils with strong activity against stationary phase Borrelia burgdorferi. Antibiotics, 9(3), 128.
- Theel, E. S. (2016). The past, present, and (possible) future of serologic testing for Lyme disease. Journal of Clinical Microbiology, 54(5), 1191-1196.
- Horowitz, R. I., & Freeman, P. R. (2019). Precision medicine: retrospective chart review and data analysis of 200 patients on dapsone combination therapy for chronic Lyme disease/post-treatment Lyme disease syndrome. International Journal of General Medicine, 12, 101-119.
- Kullberg, B. J., Vrijmoeth, H. D., van de Schoor, F., & Hovius, J. W. (2020). Lyme borreliosis: diagnosis and management. BMJ, 369, m1041.
Conclusion
This is a marathon, not a sprint. But you can get your life back.
Book Your Diagnostic. Let's find the intruder.
Frequently Asked Questions
Common Questions
Deep-Dive Questions
Ready when you are
Dr. Ash reads every intake himself, and answers questions personally - usually within a few hours.





